Income Statement

DNA X, INC.

SONM
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY
Revenue
58.30 93.63 69.83 54.57 63.99 116.25
Cost of Revenue
48.38 74.31 58.21 48.16 48.78 81.74
Gross Profit
9.92 19.32 11.62 6.41 15.21 35.99
Operating Expenses
43.56 18.81 25.91 44.42 44.47 59.57
Research & Development
14.24 1.77 7.97 17.70 16.22 28.74
Selling, General & Administrative
12.96 8.77 9.61 10.28 10.41 16.18
Other Operating Expenses
- - - - - -
Operating Income
-33.64 0.51 -14.29 -38.00 -29.26 -23.58
Non-Operating Income
-0.22 0.23 -0.39 0.46 1.19 2.07
Interest Income
- - - - - -
Interest Expense
- - 0.10 - - -
Other Non-Op Income / Expense
0.25 -0.21 0.48 -0.46 -0.43 -0.54
Income Before Tax
-33.42 0.28 -13.90 -38.46 -30.45 1.19
Income Tax Expense
0.23 0.37 0.18 0.17 -0.52 0.19
Non-Controlling Interest
- - - - - -
Net Income
-33.65 -0.09 -14.09 -38.63 -29.93 -25.83
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY
Depreciation & Amortization
- - - - - -
EBITDA
-30.08 2.72 -11.92 -35.87 -26.53 -20.05
Earnings Per Share (Basic)
-7.13 0.00 -0.49 - - -
Diluted EPS
-7.13 0.00 - - - -
Weighted Average Shares
4.72 41.69 28.89 - - -
Diluted Weighted Avg Shares
4.72 41.69 - - - -
Comprehensive Income
- - - - - -